Journal Basic Info

  • Impact Factor: 1.995**
  • H-Index: 8
  • ISSN: 2474-1647
  • DOI: 10.25107/2474-1647
**Impact Factor calculated based on Google Scholar Citations. Please contact us for any more details.

Major Scope

  •  Gynecological Surgery
  •  Emergency Surgery
  •  Urology
  •  Colon and Rectal Surgery
  •  Minimally Invasive Surgery
  •  Cardiovascular Surgery
  •  General Surgery
  •  Orthopaedic Surgery


Citation: Clin Surg. 2021;6(1):3087.Research Article | Open Access

Clinical Evaluation of Adeno-Tonsillar Hyperplasia in Non-Syndromic Children and Adolescents during Growth Hormone Treatment

Renata Nasser1 , Thalita Vervloet2 , Claudia A Eckley1 , Stefano Amade1 , Vinicius Dokkedal Silva3 , Gabriel N Pires3 , Monica L Andersen3 , Sergio Tufik3 , Carlos Longui2 , Rodolfo Scalia1 and Sandra D Xavier1,3*

Department of Otorhinolaryngology, Santa Casa Misericórdia de São Paulo, Brazil 2 Department of Pediatric Endocrinology, Santa Casa Misericórdia de São Paulo, Brazil 3 Department of Psychobiology, Federal University of São Paulo, Brazil

*Correspondance to: Sandra D Xavier 

 PDF  Full Text DOI: 10.25107/2474-1647.3087


Objective: To evaluate the difference in size of pharyngeal and palatine tonsils in patients aged between 5 and 17 being treated with recombinant human Growth Hormone (rhGH). Material and Methods: We conducted a prospective longitudinal observational study. Twelve patients in treatment with rhGH were evaluated by otorhinolaryngological physical examination, nasofibrolaryngoscopy and Obstructive Sleep Apnea (OSA)-18 questionnaire in two different timepoints: when selected (T0) and after 6 months (T1). Results: No significant associations were found regarding palatine and pharyngeal tonsil size with rhGH treatment. In relation to OSA-18 questionnaires, there was no statistically significant result in the absence of covariables for the general score as well as for the five domains that it comprises. When covariables were included in the analyses, controlled by the patient?s age, we observed statistically significant increases in the general score and in the domains relating to sleep disorders, emotional suffering, diurnal problems and the caretaker?s concerns. Conclusion: In the present study, pharyngeal or palatine tonsils hyperplasia was infrequent during treatment with rhGH in the non-syndromic children and adolescents. However, the impacts on sleep and quality of life that may arise warrant careful monitoring during therapy.


Adenoids; Pathology; Child; Human growth hormone; Adverse effects; Palatine tonsil; Pathology; Sleep apnea syndromes

Cite the article

Nasser R, Vervloet T, Eckley CA, Amade S, Dokkedal-Silva V, Pires GN, et al. Clinical Evaluation of AdenoTonsillar Hyperplasia in Non-Syndromic Children and Adolescents during Growth Hormone Treatment. Clin Surg. 2021; 6: 3087..

Search Our Journal

Journal Indexed In

Articles in PubMed

RAF Kinase Inhibitory Protein Expression and Phosphorylation Profiles in Oral Cancers
 PubMed  PMC  PDF  Full Text
Monitoring an Ongoing Enhanced Recovery after Surgery (ERAS) Program: Adherence Improves Clinical Outcomes in a Comparison of Three Thousand Colorectal Cases
 PubMed  PMC  PDF  Full Text
View More...

Articles with Grants

LODDS was a Better Predictor for Lymph Node Status and was a Dependent Poor Prognostic Factor for Distal Extrahepatic Cholangiocarcinoma after Radical Surgical Resection
 Abstract  PDF  Full Text
Hepatectomy for a Patient with Polycystic Liver Disease Associated with Cystobiliary Communication: A Case Report
 Abstract  PDF  Full Text
View More...